DS
NBP

David Shaw’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

David Shaw’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$565K – 5339
2022
Q2 		$565K Buy
+50,000
New +$599K ﹤0.01% 4023

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's NBP Position: Q2 2023 in Review

David Shaw sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 17,266 shares — an estimated $59.7K sold.

David Shaw first reported a position in NBP in Q1 2021 and held it in 9 quarters. The position peaked at $16M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

  • David Shaw reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • David Shaw sold 17,266 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $59.7K.
  • David Shaw first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 9 quarters.
  • David Shaw's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.